Regado Biosciences' Series D Round

Regado Biosciences raised a round of funding on December 17, 2009.

Regado Biosciences, a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. The Company provides REG1 that is used in patients sufferin…

Articles about Regado Biosciences' Series D Round: